Filtered By:
Vaccination: Shingles (Herpes Zoster) Vaccine
This page shows you your search results in order of relevance. This is page number 20.
Order by Relevance | Date
Total 1783 results found since Jan 2013.
Herpes Zoster Ophthalmicus in a Healthy Toddler Fully Immunized Against Varicella-Zoster Virus: A Case Report and Review of Treatment Strategies in Children
We present a complex case of HZO in a varicella zoster virus (VZV)-vaccinated toddler successfully treated with acyclovir and topical steroids. We also present a review of the relevant literature regarding the therapeutic management and long-term sequelae of HZO in children.PMID:36751223 | PMC:PMC9897126 | DOI:10.7759/cureus.33352
Source: Herpes - February 8, 2023 Category: Infectious Diseases Authors: Paraskevi Keramida Marita Antoniadi Eugenia Archimandritou Stavroula Kostaridou Patra Koletsi Source Type: research
A Cross-Sectional Study of the Knowledge, Practice, and Attitude Towards Herpes Zoster Vaccination Among the General Population in the Western Region of Saudi Arabia
Conclusion The general Saudi population had a good understanding of HZ and its vaccine. Their attitudes toward the HZ vaccine were generally positive; however, poor practices were observed. We recommend that arranging national campaigns targeting at-risk populations can enhance awareness about herpes zoster and its vaccine, subsequently increasing the rate of HZ immunization.PMID:36756021 | PMC:PMC9902051 | DOI:10.7759/cureus.33508
Source: Herpes - February 9, 2023 Category: Infectious Diseases Authors: Omar S Alhothali Ammar S Alhothali Azzam A Hanif Mohammed F Bondagji Hazem M Aljabri Reda Goweda Source Type: research
Truncated glycoprotein E of varicella-zoster virus is an ideal immunogen for Escherichia coli-based vaccine design
In conclusion, this method of E. coli-mediate tgE expression offers a cost-effective and scalable strategy to generate an ideal VZV gE immunogen for the development of both varicella and zoster vaccines.PMID:36790656 | PMC:PMC9930067 | DOI:10.1007/s11427-022-2264-1
Source: Herpes - February 15, 2023 Category: Infectious Diseases Authors: Tingting Chen Jie Sun Sibo Zhang Tingting Li Liqin Liu Wenhui Xue Lizhi Zhou Siting Liang Zhili Yu Qingbing Zheng Hai Yu Tong Cheng Jun Zhang Ying Gu Shaowei Li Ningshao Xia Source Type: research
A Case of Disseminated Herpes Zoster With Polyneuropathy Following the Third Dose of the Pfizer-BioNTech Vaccine
We report a case of disseminated herpes zoster with polyneuropathy and cerebrospinal fluid (CSF) findings following the Pfizer-BioNTechvaccine. Our observation aims to increase clinicians' awareness of a possible relationship between herpes zoster reactivation and SARS-CoV-2 vaccines.PMID:36820114 | PMC:PMC9938650 | DOI:10.7759/cureus.33962
Source: Herpes - February 23, 2023 Category: Infectious Diseases Authors: Muhammad Riazuddin Mona H Jefri Muhammad I Butt Hathami I Alsalamah Aamir Nadeem M Ali Sheikh Source Type: research
Epidemiology of Herpes Zoster in the pre-vaccination era: establishing the baseline for vaccination programme's impact in Spain
ConclusionOf all patients hospitalised with HZ, those with greater risk of mortality or readmission belonged to the groups prioritised by the current vaccination recommendations of the Spanish Ministry of Health. Our study provided relevant information on clinical aspects of HZ and established the base for future assessments of vaccination policies.PMID:36820639 | PMC:PMC9951257 | DOI:10.2807/1560-7917.ES.2023.28.8.2200390
Source: Herpes - February 23, 2023 Category: Infectious Diseases Authors: Carlos Risco Risco Zaida Herrador Noem í Lopez-Parea Diego Mart ínez-Urbistondo Rafael Su árez Del Villar Carrero Josefa Masa-Calles Source Type: research
A Case of Disseminated Herpes Zoster With Polyneuropathy Following the Third Dose of the Pfizer-BioNTech Vaccine
We report a case of disseminated herpes zoster with polyneuropathy and cerebrospinal fluid (CSF) findings following the Pfizer-BioNTechvaccine. Our observation aims to increase clinicians' awareness of a possible relationship between herpes zoster reactivation and SARS-CoV-2 vaccines.PMID:36820114 | PMC:PMC9938650 | DOI:10.7759/cureus.33962
Source: Herpes - February 23, 2023 Category: Infectious Diseases Authors: Muhammad Riazuddin Mona H Jefri Muhammad I Butt Hathami I Alsalamah Aamir Nadeem M Ali Sheikh Source Type: research
Epidemiology of Herpes Zoster in the pre-vaccination era: establishing the baseline for vaccination programme's impact in Spain
ConclusionOf all patients hospitalised with HZ, those with greater risk of mortality or readmission belonged to the groups prioritised by the current vaccination recommendations of the Spanish Ministry of Health. Our study provided relevant information on clinical aspects of HZ and established the base for future assessments of vaccination policies.PMID:36820639 | PMC:PMC9951257 | DOI:10.2807/1560-7917.ES.2023.28.8.2200390
Source: Euro Surveill - February 23, 2023 Category: Infectious Diseases Authors: Carlos Risco Risco Zaida Herrador Noem í Lopez-Parea Diego Mart ínez-Urbistondo Rafael Su árez Del Villar Carrero Josefa Masa-Calles Source Type: research
Herpes zoster ophthalmicus after COVID-19 vaccine booster in healthy younger adult: a case report
Clin Exp Vaccine Res. 2023 Jan;12(1):82-84. doi: 10.7774/cevr.2023.12.1.82. Epub 2023 Jan 31.ABSTRACTThere were growing reports of herpes zoster reactivation after the coronavirus disease 2019 (COVID-19) vaccination, including a more severe form, herpes zoster ophthalmicus (HZO). A 35-year-old male presented HZO in his left V1 dermatome 10 days after his COVID-19 vaccine booster with Moderna (messenger RNA-1273). He had no history of chronic disease, immunocompromised, autoimmune, malignancy, or long-term immunosuppressive drug use. The rash improved without any further complications after being treated with oral valacyclo...
Source: Herpes - February 27, 2023 Category: Infectious Diseases Authors: Zamrud Wilda Nuril Awaly Source Type: research
Epidemiology of Herpes Zoster in the pre-vaccination era: establishing the baseline for vaccination programme's impact in Spain
ConclusionOf all patients hospitalised with HZ, those with greater risk of mortality or readmission belonged to the groups prioritised by the current vaccination recommendations of the Spanish Ministry of Health. Our study provided relevant information on clinical aspects of HZ and established the base for future assessments of vaccination policies.PMID:36820639 | PMC:PMC9951257 | DOI:10.2807/1560-7917.ES.2023.28.8.2200390
Source: Euro Surveill - February 23, 2023 Category: Infectious Diseases Authors: Carlos Risco Risco Zaida Herrador Noem í Lopez-Parea Diego Mart ínez-Urbistondo Rafael Su árez Del Villar Carrero Josefa Masa-Calles Source Type: research
Herpes Simplex Virus and Varicella Zoster Virus Infections in Cancer Patients
Viruses. 2023 Feb 5;15(2):439. doi: 10.3390/v15020439.ABSTRACTHerpes simplex virus (HSV) and varicella zoster virus (VZV) are alpha herpesviruses that establish life-long latent infection in neuronal ganglia after primary infection. Periodic reactivation of these viruses results in recurrent infections that can have significant impact on patients' quality of life. HSV commonly causes oral and genital mucocutaneous infections whereas VZV is responsible for varicella/chickenpox and herpes zoster/shingles, but cancer patients are at particularly higher risk of complications including disseminated and visceral infections due t...
Source: Herpes - February 28, 2023 Category: Infectious Diseases Authors: Ralph Tayyar Dora Ho Source Type: research
Effectiveness of Live Attenuated Varicella-Zoster Vaccine in Adults Older than 50 Years in Japan: A Retrospective Cohort Study
Conclusion: Freeze-dried live attenuated varicella-zoster vaccine reduces the risk of HZ regardless of age, sex, or comorbidities.PMID:36851138 | PMC:PMC9958742 | DOI:10.3390/vaccines11020259
Source: Herpes - February 28, 2023 Category: Infectious Diseases Authors: Kazuhiro Matsumoto Satoko Ohfuji Kana Inohara Masateru Akechi Hiroko Kumashiro Motoki Ishibashi Shin Irie Yoshio Hirota Source Type: research
COVID-19, SARS-CoV-2 Vaccination, and Human Herpesviruses Infections
Vaccines (Basel). 2023 Jan 20;11(2):232. doi: 10.3390/vaccines11020232.ABSTRACTThere are several human herpesviruses. A common characteristic of infection by these viruses is latency, by which the virus assumes a non-replicative state, subverting the attentions of the host's immune response. In immunocompetent hosts, herpesviruses are immunologically controlled, although periodic virus shedding can occur. In situations where immunological control is lost, herpesviruses can reactivate and produce clinically apparent disease. It is now becoming apparent that COVID-19 or exposure to COVID-19 vaccines can exert several effects...
Source: Herpes - February 28, 2023 Category: Infectious Diseases Authors: Peter A C Maple Source Type: research
Epidemiology of Herpes Zoster in the pre-vaccination era: establishing the baseline for vaccination programme's impact in Spain
ConclusionOf all patients hospitalised with HZ, those with greater risk of mortality or readmission belonged to the groups prioritised by the current vaccination recommendations of the Spanish Ministry of Health. Our study provided relevant information on clinical aspects of HZ and established the base for future assessments of vaccination policies.PMID:36820639 | PMC:PMC9951257 | DOI:10.2807/1560-7917.ES.2023.28.8.2200390
Source: Euro Surveill - February 23, 2023 Category: Infectious Diseases Authors: Carlos Risco Risco Zaida Herrador Noem í Lopez-Parea Diego Mart ínez-Urbistondo Rafael Su árez Del Villar Carrero Josefa Masa-Calles Source Type: research
